Abera Bioscience AB Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 11, 2021 at 03:01 am EDT
Abera Bioscience AB announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was SEK 460,000 compared to SEK 169,000 a year ago. Operating loss was SEK 2.194 million compared to SEK 838,000 a year ago. Net loss was SEK 2.194 million compared to SEK 838,000 a year ago.
For the half year, total revenue was SEK 463,000 compared to SEK 475,000 a year ago. Operating loss was SEK 4.619 million compared to SEK 1.301 million a year ago. Net loss was SEK 4.619 million compared to SEK 1.301 million a year ago.